tirzepatide — the active ingredient in Zepbound and its counterpart Mounjaro for diabetes — is fully available again. "FDA has determined that the shortage of tirzepatide injection products ...

Lilly is considering expanding the availability of lower-priced vials of its blockbuster obesity drug Zepbound ...

Zepbound (tirzepatide), manufactured by Fortune 500 firm Eli Lilly & Co., bested competitor Wegovy (semaglutide), a product of Global 500 company Novo Nordisk, in a 2023–24 randomized clinical ...

The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next two to three months.

The Food and Drug Administration on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity. Zepbound is the first medication approved ...

FILE - Zepbound injection pen (Photographer: Shelby Knowles/Bloomberg via Getty Images) According to Eli ... Mounjaro’s product description warns that it could cause thyroid tumors, including ...

The Food and Drug Administration approved Zepbound as the first prescription medicine to treat sleep apnea on Friday—marking a significant win for the drug company Eli Lilly, which had Zepbound ...

Eli Lilly's stock tumbled 8% on Tuesday after it forecast fourth-quarter sales of weight-loss drug Zepbound below Wall Street ...

The "Mrs. Doubtfire" star weighed 310 pounds at his heaviest before making the decision to begin taking "Zepbound." After losing 120 pounds, Fierstein told Page Six he "put 15 back on, which I ...

The FDA removed Eli Lilly’s LLY tirzepatide injection products from the drug shortage ... 1 RA), as Mounjaro for type II diabetes (T2D) and Zepbound for obesity. Per the regulatory body, a ...